Key result
Primary angioplasty and pharmaco-invasive strategies for ST-elevated myocardial infarction require strict adherence to current guidelines to reduce ischemia time and improve patient survival.
Why the study?
Reperfusion time is crucial for survival and myocardial preservation in STEMI, requiring proper organization of care and adherence to guidelines to reduce ischemia time and avoid unjustified refusal of interventions.
This lecture reviews the choice of tactics and rules of reperfusion therapy, including primary angioplasty and pharmaco-invasive strategies, for ST-elevated myocardial infarction.
Supports current STEMI reperfusion choices; leaves open need for updated randomized comparisons of strategies.
The lecture is devoted to the choice of tactics and the rules of reperfusion therapy for ST-elevated myocardial infarction. Since the time of reperfusion is crucial for the survival of these patients and the preservation of a viable myocardium, proper organization of care and strict adherence to the guidelines for drug-induced and non-drug interventions is necessary. The lecture substantiates the tactics of pharmaco-invasive intervention, the choice of thrombolytic agent, provides data on indications and contraindications for thrombolytic therapy, dosing regimen of thrombolytic drugs, other antiplatelet and anticoagulant drugs required for reperfusion. Knowledge of current guidelines should help reduce ischemia time and cases of unjustified refusal to effective interventions.
No takes yet. Share an insight, caveat, or question.
Глезер et al. (2019) conducted a review in ST-elevated myocardial infarction. Primary angioplasty and pharmaco-invasive strategies was evaluated. Primary angioplasty and pharmaco-invasive strategies for ST-elevated myocardial infarction require strict adherence to current guidelines to reduce ischemia time and improve patient survival.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: